1. Home
  2. RVMD vs EL Comparison

RVMD vs EL Comparison

Compare RVMD & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$189.23

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo Estee Lauder Companies Inc. (The)

EL

Estee Lauder Companies Inc. (The)

HOLD

Current Price

$84.31

Market Cap

30.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
EL
Founded
2014
1946
Country
United States
United States
Employees
883
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
30.3B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
RVMD
EL
Price
$189.23
$84.31
Analyst Decision
Strong Buy
Buy
Analyst Count
19
20
Target Price
$140.84
$97.60
AVG Volume (30 Days)
1.8M
2.1M
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
1.85%
EPS Growth
N/A
N/A
EPS
N/A
0.82
Revenue
N/A
$14,326,000,000.00
Revenue This Year
N/A
$7.51
Revenue Next Year
$533.02
$4.08
P/E Ratio
N/A
$103.61
Revenue Growth
N/A
N/A
52 Week Low
$34.00
$66.22
52 Week High
$194.56
$121.64

Technical Indicators

Market Signals
Indicator
RVMD
EL
Relative Strength Index (RSI) 55.41 54.02
Support Level $176.00 $80.06
Resistance Level $193.83 $87.57
Average True Range (ATR) 7.45 2.25
MACD -0.96 0.37
Stochastic Oscillator 58.24 75.61

Price Performance

Historical Comparison
RVMD
EL

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About EL Estee Lauder Companies Inc. (The)

Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top-selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Share on Social Networks: